section name header

Y-Site Injection Compatibility (1:1 Mixture)

Vancomycin HCl

(Mfr: BA)(Conc: 5 mg/mLbb)

QMark

Piperacillin sodium-tazobactam sodium

(Mfr: PFaa)(Conc: 60 mg/mLu,bb)

Remarks:

No evidence of physical incompatibility via simulated Y-site infusion; however, a white precipitate forms during actual Y-site infusion

Ref:

3481